Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging

    COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends

    Published: February 16, 2021 | Price: $2,700.00 – $5,400.00

    As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently.  Hundreds of test products are on the market to detect the virus, both for its presence and immune response.  And billions of dollars have been added to the in vitro diagnostic market.  Companies have doubled and tripled revenues, bought new companies, increased manufacturing, shifted focus to infectious diseases and launched new products. "A 38 Billion Dollar Market...
    The Market and Future Potential for Molecular Point of Care

    Published: January 22, 2021 | Price: $4,000.00 – $8,000.00

    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT   This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...
    IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests

    Published: February 23, 2021 | Price: $4,000.00 – $8,000.00

    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business...
    Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions

    Published: January 4, 2021 | Price: $4,000.00 – $8,000.00

    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so,...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000.00 – $8,000.00

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000.00 – $6,000.00

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...
    The Market for Clinical LDT Services and LDT Supplies

    Published: September 24, 2020 | Price: $5,500.00 – $11,000.00

    Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically.  Historically, these tests were called “home-brew tests” or “in-house tests.”  Also, historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications.  Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians...
    The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition

    Published: July 31, 2020 | Price: $8,250.00 – $16,500.00

    Download Brochure What is the Size of the IVD Market in 2020? In its latest report Kalorama Information estimates the market for in vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars.   This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVD-19 testing responsible for most of the growth.  Other infectious diseases (particularly respiratory pathogens), advanced cancer IVDs and increasing used of critical care...
    Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience

    Published: July 27, 2020 | Price: $3,750.00 – $7,000.00

    Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2020 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors, clinical...
    Digital Pathology: Markets, Trends, Companies and COVID-19 Impact

    Published: July 24, 2020 | Price: $3,500.00 – $7,000.00

    Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms.  Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks.  This allows independent viewing of images by large numbers of people in diverse locations. Digital camera equipped microscopes may zoom onto a specific region on a slide to provide higher resolution of the area.  In another strategy,...
    Molecular Diagnostics Markets in the COVID-19 Era (Markets for COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)

    Published: July 9, 2020 | Price: $5,500.00 – $11,000.00

    Molecular Diagnostics could be said to be the most important part of in vitro diagnostics.  This is especially true in the wake of COVID-19.  Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a year of growth and...
    Clinical Diagnostics MasterFile

    Published: June 30, 2020 | Price:

    Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture Molecular Diagnostics Next-Generation Sequencing Urinalysis Analyzers (automated) The Kalorama Clinical Diagnostics MasterFile supports strategic planning, sales force optimization, and account-based marketing. It can be easily...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Emerging Infectious Disease Diagnostics: Markets and Trends

    Published: May 27, 2020 | Price: $3,000.00 – $6,000.00

    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
    Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

    Published: May 19, 2020 | Price: $5,000.00 – $10,000.00

    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...